This paper is the FIRST peer-reviewed and Published paper in the world to propose a Cancer Treatment Protocol based on the incredible properties of IVERMECTIN, MEBENDAZOLE and FENBENDAZOLE.
This was truly a labor of love.
My thanks to lead authors Ilyes Baghli and Pierrick Martinez for their incredible inspired work, FLCCC’s Dr.Paul Marik for his extensive work on repurposed drugs and every co-author who worked hard to bring this paper to life.
Dr William Makis on substack
Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol
Published by Journal of Orthomolecular Medicine
19 September 2024
Targeting-the-Mitochondrial-Stem-Cell-Connection-in-Cancer-Treatment-JOM-39.3
Source: https://tinyurl.com/y7dnxz5b
Dr William Makis on Twitter X @MakisMD
First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published on Sep.19, 2024!
The future of Cancer Treatment starts NOW.
My thanks to lead authors Ilyes Baghli and Pierrick Martinez for their incredible inspired work, FLCCC’s Dr.Paul Marik for his extensive work on repurposed drugs and every co-author who worked hard to bring this paper to life.
I hope that this peer-reviewed paper lays the groundwork for a brand new future for Cancer Treatment.
Many of you know that I have been helping thousands of Cancer patients with high dose Ivermectin, Mebendazole, and Fenbendazole.
We are already starting to see incredible successes with these repurposed drugs.
Mainstream Oncology collapsed after the rollout of contaminated COVID-19 mRNA Vaccines.
Most Oncologists abandoned their Hippocratic Oath, gave contaminated mRNA Vaccines to all their cancer patients and took the mRNA jabs themselves.
Some Oncologists have now developed mRNA Induced Cardiac arrests, blood clots and Turbo Cancer. Others have already died suddenly.
These Oncologists buried their heads in the sand and abandoned everything that it takes to be a good competent doctor.
However, there are doctors who are blazing a new path into the future. See you there!